[1-[2-[2-(Hydroxymethyl)-1-piperidyl]ethyl]-2-piperidyl]methanol

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 哌啶类
• 英文名称: [1-[2-[2-(Hydroxymethyl)-1-piperidyl]ethyl]-2-piperidyl]methanol
• 英文别名: [1-[2-[2-(hydroxymethyl)piperidin-1-yl]ethyl]piperidin-2-yl]methanol
• 化学式: C₁₄H₂₈N₂O₂
• 分子量: 256.38
• InChiKey: NALQGCWTPRAORB-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  0.8
• 重原子数：
  18
• 可旋转键数：
  5
• 环数：
  2.0
• sp3杂化的碳原子比例：
  1.0
• 拓扑面积：
  46.9
• 氢给体数：
  2
• 氢受体数：
  4

文献信息

• Bisarylamides of N,N'-di-[1-aminoalkyl-2]-alkylene diamines having a cardiovascular activity
  申请人：BEECHAM - WUELFING GmbH & Co. KG

  公开号：EP0174085A2

  公开（公告）日：1986-03-12

  Disclosed are compounds of formula (1) and pharmaceutically acceptable salts thereof: wherein: R, and R9 are independently phenyl, phenyl C1-4 alkyl, phenyl C2-4 alkenyl or pyridyl, the aromatic moiety optionally substituted by one, two or three of halogen, trifluoromethyl, C1-4 alkoxy, C1-4 alkyl, cyano, hydroxy, nitro, NR10R11 or O2SNR10R11 wherein R,o and R11 are independently hydrogen or C1-6 alkyl or together are C3-6 polymethylene, or disubstituted at adjacent carbon atoms by C1-2 alkylenedioxy; C3-8 cycloalkyl; or aliphatic heterocyclyl having up to six ring atoms the heteroatom(s) being selected from oxygen, sulphur or nitrogen; m and n are independently integers of 0 to 3, such that m + n is 0 to 3; and Rz and R8 are independently hydrogen C1-4 alkyl or phenyl C1-4 alkyl, R3 is C1-4 alkyl optionally substituted by hydroxy or thiol or phenyl C1-4 alkyl, or together with R4 is C3-6 polymethylene, R4 is hydrogen, C1-4 alkyl, phenyl C1-4 alkyl or as defined with R3, or together with R5 is -(CH2)p-where p is an integer from 2 to 6 such that m + p is 3 to 6, R6 is hydrogen, C1-4 alkyl or as defined with R4, or together with R6 is -(CH2)q-where q is an integer from 2 to 6 such that n + q is 3 to 6, R6 is hydrogen, C1-4 alkyl, phenyl C1-4 alkyl or as defined with R5, or together with R7 is C3-6 polymethylene, and R7 is C1-4 alkyl optionally substituted by hydroxy or thiol, phenyl C1-4 alkyl or as defined with R6, in which any phenyl moiety in R2,R3,R4,R6,R7 and R8 is optionally substituted by one or two of halogen, trifluoromethyl, C1-4 alkoxy or C1-4 alkyl. Such compounds have been found to possess cardiovascular activity, in particular calcium antagonistic activity which indicates that they are of potential use in the treatment of angina.

  所公开的是式 (1) 化合物及其药学上可接受的盐类： 其中 R和R9独立地为苯基、苯基C1-4烷基、苯基C2-4烯基或吡啶基，芳基可任选被卤素、三氟甲基、C1-4烷氧基、C1-4烷基、氰基、羟基、硝基、NR10R11或O2SNR10R11中的一个、两个或三个取代，其中R,o和R11独立地为氢或C1-6烷基或一起为C3-6多亚甲基，或在相邻碳原子上被C1-2亚烷基二氧基二取代；C3-8 环烷基；或最多有六个环原子的脂族杂环烷基，杂原子选自氧、硫或氮； m 和 n 独立地为 0 至 3 的整数，即 m + n 为 0 至 3；Rz 和 R8 独立地是氢 C1-4 烷基或苯基 C1-4 烷基，R3 是任选被羟基或硫醇取代的 C1-4 烷基或苯基 C1-4 烷基，或与 R4 一起是 C3-6 聚亚甲基，R4 是氢、C1-4 烷基、苯基 C1-4 烷基或如 R3 所定义，或与 R5 一起是-(CH2)p-其中 p 是 2 到 6 的整数，这样 m + p 是 3 到 6，R6 是氢、C1-4 烷基或如 R4 所定义、或与 R6 一起为-(CH2)q-其中 q 为 2 至 6 的整数，n + q 为 3 至 6，R6 为氢、C1-4 烷基、苯基 C1-4 烷基或如 R5 所定义，或与 R7 一起为 C3-6 聚亚甲基、和 R7 是任选被羟基或硫醇取代的 C1-4 烷基、苯基 C1-4 烷基或如 R6 所定义，其中 R2、R3、R4、R6、R7 和 R8 中的任何苯基任选被卤素、三氟甲基、C1-4 烷氧基或 C1-4 烷基中的一个或两个取代。 已发现此类化合物具有心血管活性，特别是钙拮抗活性，这表明它们具有治疗心绞痛的潜在用途。